Cedar Brook Financial Partners, LLC Johnson & Johnson Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $1.2 Million - $1.31 Million	-8,331 Reduced 81.48%	1,893 $276,000
Q1 2024 Apr 17, 2024	SELL	$155.22 - $162.74 $22,351 - $23,434	-144 Reduced 1.39%	10,224 $1.62 Million
Q4 2023 Jan 12, 2024	BUY	$145.6 - $158.88 $80,808 - $88,178	555 Added 5.66%	10,368 $1.63 Million
Q3 2023 Oct 17, 2023	SELL	$155.75 - $174.48 $67,439 - $75,549	-433 Reduced 4.23%	9,813 $1.53 Million
Q2 2023 Jul 05, 2023	BUY	$154.35 - $166.11 $113,138 - $121,758	733 Added 7.71%	10,246 $1.7 Million
Q1 2023 Apr 04, 2023	BUY	$151.05 - $180.26 $37,007 - $44,163	245 Added 2.64%	9,513 $1.47 Million
Q4 2022 Feb 01, 2023	SELL	$160.2 - $179.79 $114,222 - $128,190	-713 Reduced 7.14%	9,268 $1.64 Million
Q3 2022 Jan 03, 2023	SELL	$161.33 - $179.52 $6,775 - $7,539	-42 Reduced 0.42%	9,981 $1.63 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $13,455 - $14,880	80 Added 0.8%	10,023 $1.78 Million
Q1 2022 Apr 06, 2022	BUY	$158.14 - $179.59 $98,679 - $112,064	624 Added 6.7%	9,943 $1.76 Million
Q4 2021 Jan 27, 2022	SELL	$155.93 - $173.01 $98,859 - $109,688	-634 Reduced 6.37%	9,319 $1.59 Million
Q3 2021 Nov 01, 2021	BUY	$161.5 - $179.47 $28,424 - $31,586	176 Added 1.8%	9,953 $1.61 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $219,922 - $235,905	1,379 Added 16.42%	9,777 $1.61 Million
Q1 2021 May 11, 2021	SELL	$153.07 - $170.48 $45,155 - $50,291	-295 Reduced 3.39%	8,398 $1.38 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $18,235 - $20,931	-133 Reduced 1.51%	8,693 $1.37 Million
Q3 2020 Nov 09, 2020	BUY	$140.38 - $153.83 $11,791 - $12,921	84 Added 0.96%	8,826 $1.31 Million
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $67,754 - $81,798	526 Added 6.4%	8,742 $1.23 Million
Q1 2020 May 07, 2020	SELL	$111.14 - $153.99 $111 - $153	-1 Reduced 0.01%	8,216 $1.08 Million
Q4 2019 Feb 06, 2020	SELL	$127.5 - $146.44 $102,892 - $118,177	-807 Reduced 8.94%	8,217 $1.2 Million
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $175,191 - $196,153	-1,380 Reduced 13.26%	9,024 $1.17 Million
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $112,657 - $123,902	-859 Reduced 7.63%	10,404 $1.45 Million
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $6,663 - $7,408	53 Added 0.47%	11,263 $1.57 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $1.38 Million - $1.66 Million	11,210 New	11,210 $1.45 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account